NHS England has mandated the use of dm+d codes

NHS England has mandated the use of dm+d codes for licensed medicines by June 2017 in the standard ISB0052. CIS Oncology is pleased to announce that this requirement is addressed in ChemoCare Version 6.02, using First Databanks's Multilex drug knowledge.
http://www.fdbhealth.co.uk/solutions/multilex/


This new functionality also supports allergy and interaction checking for drugs prescribed in ChemoCare and other medicines registered in the system. To enable access to the Multilex drug knowledge, users map drugs configured in ChemoCare to the drug data in Multilex, which contains dm+d coding of drugs held within the database.

For further information please email info@cis-healthcare.com or call us on +44 (0)2895 600830.

CIS Oncology